Mast-cell responses to pathogens, Nat Rev Immunol, vol.4, pp.787-799, 2004. ,
Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells, Front Immunol, vol.5, p.453, 2014. ,
IgA Fc receptors, Annu Rev Immunol, vol.21, pp.177-204, 2003. ,
Identification of FcalphaRI as an inhibitory receptor that controls inflammation: Dual role of FcRgamma ITAM, Immunity, vol.22, pp.31-42, 2005. ,
Immunoglobulin D enhances interleukin-6 release from the KU812 human prebasophil cell line, Gen Physiol Biophys, vol.22, pp.255-263, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00282548
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cellstimulating programs in basophils, Nat Immunol, vol.10, pp.889-898, 2009. ,
Activation of human mast cells through the high affinity IgG receptor, Mol Immunol, vol.38, pp.1289-1293, 2002. ,
Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma, J Immunol, vol.164, pp.4332-4339, 2000. ,
Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients, Clin Immunol, vol.125, pp.149-158, 2007. ,
Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes, J Biol Chem, vol.279, pp.35139-35149, 2004. ,
Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells, J Immunol, vol.177, pp.694-701, 2006. ,
Murine recombinant Fc gamma RIII, but not Fc gamma RII, trigger serotonin release in rat basophilic leukemia cells, J Immunol, vol.149, pp.1365-1373, 1992. ,
Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit, J Immunol, vol.149, pp.2155-2162, 1992. ,
Peritoneal cell-derived mast cells: An in vitro model of mature serosal-type mouse mast cells, J Immunol, vol.178, pp.6465-6475, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00181324
Of ITIMs, ITAMs, and ITAMis: Revisiting immunoglobulin Fc receptor signaling, Immunol Rev, vol.268, pp.66-73, 2015. ,
Mast cells and company, Front Immunol, vol.3, p.16, 2012. ,
Regulation of immune cell signaling by SHIP1: A phosphatase, scaffold protein, and potential therapeutic target, Eur J Immunol, vol.47, pp.932-945, 2017. ,
The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation, Proc Natl Acad Sci, vol.95, pp.11330-11335, 1998. ,
Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses, Blood, vol.113, pp.3716-3725, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00363931
Complementation of Der P 2-induced histamine release from human basophils sensitized with monoclonal IgE: Not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2, J Allergy Clin Immunol, vol.101, pp.404-409, 1998. ,
An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.185, pp.817-824, 2012. ,
Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps, Allergy, vol.67, pp.1165-1172, 2012. ,
Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis, PLoS ONE, vol.6, p.25392, 2011. ,
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation, Oncotarget, vol.5, pp.3159-3167, 2014. ,
Atopic and non-atopic allergic disorders: Current insights into the possible involvement of free immunoglobulin light chains, Clin Exp Allergy, vol.39, pp.33-42, 2009. ,
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity, Ann Rheum Dis, vol.69, pp.2137-2144, 2010. ,
Elicitation of allergic asthma by immunoglobulin free light chains, Proc Natl Acad Sci USA, vol.102, pp.1578-1583, 2005. ,
Effects of free immunoglobulin light chains on viral myocarditis, Circ Res, vol.106, pp.1533-1540, 2010. ,
Polyclonal immunoglobulin free light chain and chronic inflammation, Mayo Clin Proc, vol.87, pp.1032-1033, 2012. ,
Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases, J Immunol, vol.185, pp.653-659, 2010. ,
Contribution of IgE and immunoglobulin free light chain in the allergic reaction to cow's milk proteins, J Allergy Clin Immunol, vol.125, pp.1308-1314, 2010. ,
Free immunoglobulin light chains: A novel target in the therapy of inflammatory diseases, Trends Pharmacol Sci, vol.29, pp.170-174, 2008. ,
Immunoglobulinfree light chains elicit immediate hypersensitivity-like responses, Nat Med, vol.8, pp.694-701, 2002. ,
Antigen binding characteristics of immunoglobulin free light chains: Crosslinking by antigen is essential to induce allergic inflammation, PLoS ONE, vol.7, p.40986, 2012. ,
TLR signaling in mast cells: Common and unique features, Front Immunol, vol.3, p.185, 2012. ,
Increased toll-like receptors activity and TLR ligands in patients with autoimmune thyroid diseases, Front Immunol, vol.7, p.578, 2016. ,
Expression of surface and intracellular Toll-like receptors by mature mast cells, Cent Eur J Immunol, vol.41, pp.333-338, 2016. ,
Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands, Exp Dermatol, vol.18, pp.437-444, 2009. ,
Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming, Immunol Lett, vol.109, pp.138-144, 2007. ,
Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells, Eur J Immunol, vol.33, pp.899-906, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00282565
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, J Clin Invest, vol.109, pp.1351-1359, 2002. ,
Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan, Immunol Lett, vol.88, pp.21-26, 2003. ,
FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells, Blood, vol.107, pp.610-618, 2006. ,
The modulatory effect of TLR2 on LL-37-induced human mast cells activation, Biochem Biophys Res Commun, vol.470, pp.368-374, 2016. ,
Differential effects of the Toll-like receptor 2 agonists, PGN and Pam3CSK4 on anti-IgE induced human mast cell activation, PLoS ONE, vol.9, p.112989, 2014. ,
Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2, J Allergy Clin Immunol, vol.120, pp.452-461, 2007. ,
Substance P primes lipoteichoic acid-and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2, Immunology, vol.131, pp.220-230, 2010. ,
Toll-like receptor 2-mediated MAPKs and NF-kappaB activation requires the GNAO1-dependent pathway in human mast cells, Integr Biol (Camb), vol.8, pp.968-975, 2016. ,
Accessory molecules for Toll-like receptors and their function, Nat Rev Immunol, vol.12, pp.168-179, 2012. ,
TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells, J Immunol, vol.173, pp.531-541, 2004. ,
Toll-like receptor 4-mediated activation of murine mast cells, J Leukoc Biol, vol.70, pp.977-984, 2001. ,
Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4, J Immunol, vol.167, pp.2250-2256, 2001. ,
MD-2 is required for the full responsiveness of mast cells to LPS but not to PGN, Biochem Biophys Res Commun, vol.323, pp.491-498, 2004. ,
Activation of mast cells by double-stranded RNA: Evidence for activation through Tolllike receptor 3, J Allergy Clin Immunol, vol.114, pp.174-182, 2004. ,
TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin, Mol Immunol, vol.43, pp.1579-1586, 2006. ,
Lipopolysaccharide/TLR4 stimulates IL-13 production through a MyD88-BLT2-linked cascade in mast cells, potentially contributing to the allergic response, J Immunol, vol.199, pp.409-417, 2017. ,
Lipopolysaccharide suppresses IgEmast cell mediated reactions, Clin Exp Allergy, vol.47, pp.1574-1585, 2017. ,
About the role and underlying mechanisms of cofactors in anaphylaxis, Allergy, vol.68, pp.1085-1092, 2013. ,
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, vol.410, pp.1099-1103, 2001. ,
Flagellin modulates TIM4 expression in mast cells, Cell Biol Int, vol.38, pp.1330-1336, 2014. ,
Innate immune pattern recognition: A cell biological perspective, Annu Rev Immunol, vol.33, pp.257-290, 2015. ,
Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms, Cell Mol Immunol, vol.12, pp.192-201, 2015. ,
TLR3-induced activation of mast cells modulates CD8 + T-cell recruitment, Blood, vol.106, pp.978-987, 2005. ,
Influenza A viruses replicate productively in mouse mastocytoma cells (P815) and trigger proinflammatory cytokine and chemokine production through TLR3 signaling pathway, Front Microbiol, vol.7, p.2130, 2016. ,
Tyrosine phosphorylation in Toll-like receptor signaling, Cytokine Growth Factor Rev, vol.25, pp.533-541, 2014. ,
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, Nat Immunol, vol.3, pp.196-200, 2002. ,
Mast cells generate cysteinyl leukotrienes and interferon-beta as well as evince impaired IgE-dependent degranulation upon TLR7 engagement, Indian J Exp Biol, vol.52, pp.589-596, 2014. ,
Toll-like receptors and RBL-2H3 mast cells, Inflamm Res, vol.58, issue.1, pp.11-12, 2009. ,
The tolllike receptor repertoire of human B lymphocytes: Inducible and selective expression of TLR9 and TLR10 in normal and transformed cells, Blood, vol.102, pp.956-963, 2003. ,
Signalling C-type lectin receptors, microbial recognition and immunity, Cell Microbiol, vol.16, pp.185-194, 2014. ,
Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism, J Allergy Clin Immunol, vol.118, pp.837-843, 2006. ,
Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells, J Biol Chem, vol.289, pp.31565-31575, 2014. ,
Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation, Immunobiology, vol.214, pp.321-330, 2009. ,
Mast cells phagocyte Candida albicans and produce nitric oxide by mechanisms involving TLR2 and Dectin-1, Immunobiology, vol.221, pp.220-227, 2016. ,
CD48: A co-stimulatory receptor of immunity, Int J Biochem Cell Biol, vol.43, pp.25-28, 2011. ,
The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositolanchored molecule CD48, Proc Natl Acad Sci USA, vol.96, pp.8110-8115, 1999. ,
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha, Nature, vol.381, pp.77-80, 1996. ,
Human mast cell activation by Staphylococcus aureus: Interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules, Infect Immun, vol.76, pp.4489-4497, 2008. ,
Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis, FEMS Microbiol Lett, vol.197, pp.131-138, 2001. ,
Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection, J Innate Immun, vol.5, pp.163-173, 2013. ,
Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling, J Immunol, vol.190, pp.4676-4684, 2013. ,
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance, Proc Natl Acad Sci, vol.108, pp.9190-9195, 2011. ,
RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection, PLoS ONE, vol.7, p.34055, 2012. ,
Dengue virus selectively induces human mast cell chemokine production, J Virol, vol.76, pp.8408-8419, 2002. ,
Roles of retinoic acidinducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2?-5? oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection, Immunol Res, vol.61, pp.240-249, 2015. ,
Human cord blood-derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines, J Innate Immun, vol.3, pp.142-149, 2011. ,
Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea, Am J Pathol, vol.171, pp.537-547, 2007. ,
Critical role for mast cells in interleukin-1beta-driven skin inflammation associated with an activating mutation in the nlrp3 protein, Immunity, vol.37, pp.85-95, 2012. ,
Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: Preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells, Clin Immunol, vol.130, pp.175-185, 2009. ,
Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: The role of TLR2 and NOD2, Immunol Cell Biol, vol.85, pp.538-545, 2007. ,
NOD1 and NOD2 interact with the phagosome cargo in mast cells: A detailed morphological evidence, Inflammation, vol.38, pp.1113-1125, 2015. ,
Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria, J Exp Med, vol.206, pp.1037-1046, 2009. ,
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder, Immunity, vol.20, pp.319-325, 2004. ,
Linkage of bacterial colonization of skin and the urticaria-like rash of NLRP3-mediated autoinflammatory syndromes through mast cell-derived TNF-alpha, J Dermatol Sci, vol.71, pp.83-88, 2013. ,
Seven-transmembrane receptors, Nat Rev Mol Cell Biol, vol.3, pp.639-650, 2002. ,
G protein pathways, Science, vol.296, pp.1636-1639, 2002. ,
Physiological roles of G protein-coupled receptor kinases and arrestins, Annu Rev Physiol, vol.69, pp.511-534, 2007. ,
Histamine release by compounds of simple chemical structure, Pharmacol Rev, vol.9, pp.269-328, 1957. ,
Agents that release histamine from mast cells, Annu Rev Pharmacol Toxicol, vol.23, pp.331-351, 1983. ,
Occurrence of heparin in the invertebrate styela plicata (Tunicata) is restricted to cell layers facing the outside environment. An ancient role in defense?, J Biol Chem, vol.275, pp.36189-36186, 2000. ,
Identification of a mast-cellspecific receptor crucial for pseudo-allergic drug reactions, Nature, vol.519, pp.237-241, 2015. ,
The presence of histamine in tissue mast cells, J Physiol, vol.120, pp.528-537, 1953. ,
Roles of Mas-related G proteincoupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases, J Allergy Clin Immunol, vol.138, pp.700-710, 2016. ,
Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors, Biochem Biophys Res Commun, vol.349, pp.1322-1328, 2006. ,
Peptide-mediated mast cell activation: Ligand similarities for receptor recognition and protease-induced regulation, J Leukoc Biol, vol.102, pp.237-251, 2017. ,
New insights into the antimicrobial effect of mast cells against Enterococcus faecalis, Infect Immun, vol.82, pp.4496-4507, 2014. ,
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen, Vaccine, vol.27, pp.3544-3552, 2009. ,
Neuroendocrinology of mast cells: Challenges and controversies, Exp Dermatol, vol.26, pp.751-759, 2017. ,
Theorien über die Anaphylaxie, Z Immunitätsforschung Exp Ther, vol.2, pp.208-224, 1909. ,
Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin, J Exp Med, vol.110, pp.311-339, 1959. ,
Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator, J Exp Med, vol.137, pp.1109-1123, 1973. ,
Release of histamine from rat mast cells by the complement peptides C3a and C5a, Immunology, vol.28, pp.1067-1080, 1975. ,
The chemotactic receptor for human C5a anaphylatoxin, Nature, vol.349, pp.614-617, 1991. ,
Expression of high-and lowaffinity receptors for C3a on the human mast cell line, HMC-1, Eur J Immunol, vol.26, pp.753-758, 1996. ,
Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a, Immunol Lett, vol.128, pp.36-45, 2010. ,
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells, J Immunol, vol.155, pp.3152-3160, 1995. ,
Tyrosine kinase inhibitors -A review on pharmacology, metabolism and side effects, Curr Drug Metab, vol.10, pp.470-481, 2009. ,
The effect of human anaphylatoxins and neutrophils on histamine release from isolated human skin mast cells, J Dermatol, vol.19, pp.19-26, 1992. ,
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway, J Immunol, vol.157, pp.1693-1698, 1996. ,
Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor, BMC Immunol, vol.9, p.29, 2008. ,
Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg, Am J Pathol, vol.138, pp.1359-1369, 1991. ,
A mechanism of action for anaphylatoxin C3a stimulation of mast cells, J Immunol, vol.148, pp.2456-2461, 1992. ,
Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice, J Allergy Clin Immunol, vol.131, pp.541-549, 2013. ,
Endothelin system: The doubleedged sword in health and disease, Annu Rev Pharmacol Toxicol, vol.41, pp.851-876, 2001. ,
Evidence that the endothelin A receptor can enhance IgE-dependent anaphylaxis in mice, J Allergy Clin Immunol, vol.128, pp.424-426, 2011. ,
Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin, J Exp Med, vol.204, pp.2629-2639, 2007. ,
Mast cells promote homeostasis by limiting endothelin-1-induced toxicity, Nature, vol.432, pp.512-516, 2004. ,
The role of neurotensin in physiologic and pathologic processes, Curr Opin Endocrinol Diabetes Obes, vol.18, pp.75-82, 2011. ,
Neuroendocrinology of the skin, Rev Endocr Metab Disord, vol.17, pp.287-294, 2016. ,
HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1, Inflamm Res, vol.60, pp.1139-1151, 2011. ,
Mast cell binding of neurotensin. I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites, J Biol Chem, vol.252, pp.7174-7179, 1977. ,
Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis, Nat Med, vol.14, pp.392-398, 2008. ,
Functional coupling with Galpha(q) and Galpha(i1) protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli, FEBS Lett, vol.493, pp.101-105, 2001. ,
Neurotensin and CRH interactions augment human mast cell activation, PLoS ONE, vol.7, p.48934, 2012. ,
Insights into mechanisms of corticotropinreleasing hormone receptor signal transduction, Br J Pharmacol, vol.166, pp.85-97, 2011. ,
Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice, Am J Pathol, vol.176, pp.926-938, 2010. ,
Neuropeptides activate human mast cell degranulation and chemokine production, Immunology, vol.123, pp.398-410, 2008. ,
Use of NK(1) knockout mice to analyze substance P-induced edema formation, Am J Physiol, vol.277, pp.476-481, 1999. ,
Increase of mast cell-nerve association and neuropeptide receptor expression on mast cells in perennial allergic rhinitis, NeuroImmunoModulation, vol.23, pp.261-270, 2016. ,
Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor, J Immunol, vol.171, pp.2074-2079, 2003. ,
Dual action of neurokinin-1 antagonists on Mas-related GPCRs, JCI Insight, vol.1, p.89362, 2016. ,
Substance P activates Masrelated G protein-coupled receptors to induce itch, J Allergy Clin Immunol, vol.140, pp.447-453, 2017. ,
Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide, Cephalalgia, vol.17, pp.166-174, 1997. ,
Mast cells and inflammation, Biochim Biophys Acta, vol.1822, pp.21-33, 2012. ,
Calcitonin generelated peptide: Physiology and pathophysiology, Physiol Rev, vol.94, pp.1099-1142, 2014. ,
Calcitonin gene-related peptide (CGRP): A new target for migraine, Annu Rev Pharmacol Toxicol, vol.55, pp.533-552, 2015. ,
Release of vasoactive intestinal polypeptide in mast cells by histamine liberators, Nature, vol.275, pp.661-662, 1978. ,
Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells, Cell Immunol, vol.151, pp.369-378, 1993. ,
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): Its therapeutic potential in inflammatory disease, Clin Exp Immunol, vol.157, pp.225-234, 2009. ,
Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems, Exp Dermatol, vol.7, pp.81-96, 1998. ,
Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats, Neurogastroenterol Motil, vol.25, pp.406-417, 2013. ,
Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin, Nature, vol.321, pp.75-79, 1986. ,
, Handb Exp Pharmacol, vol.237, pp.23-40, 2017.
Beta-adrenoceptors and asthma, Clin Exp Allergy, vol.23, pp.165-167, 1993. ,
Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli, J Immunol, vol.114, pp.1473-1479, 1975. ,
Bidirectional counterregulation of human lung mast cell and airway smooth muscle beta2 adrenoceptors, J Immunol, vol.196, pp.55-63, 2016. ,
Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function, Eur J Pharmacol, vol.778, pp.56-67, 2016. ,
Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis, J Exp Med, vol.199, pp.959-970, 2004. ,
The sphingosine kinasesphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis, Immunity, vol.26, pp.287-297, 2007. ,
Mast cells and eicosanoid mediators: A system of reciprocal paracrine and autocrine regulation, Immunol Rev, vol.217, pp.168-185, 2007. ,
Murine bone marrowderived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2), Int Immunol, vol.21, pp.621-632, 2009. ,
Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis, Nat Immunol, vol.14, pp.554-563, 2013. ,
Expression of DP2 (CRTh2), a prostaglandin D(2) receptor, in human mast cells, PLoS ONE, vol.9, p.108595, 2014. ,
Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation, Am J Respir Crit Care Med, vol.159, pp.31-36, 1999. ,
Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses, Blood, vol.107, pp.3243-3250, 2006. ,
Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism, J Immunol, vol.165, pp.6545-6552, 2000. ,
E-prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA-mediated suppression of IgE-dependent signaling, J Leukoc Biol, vol.92, pp.1155-1165, 2012. ,
Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration, Eur J Immunol, vol.38, pp.2548-2556, 2008. ,
Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation, Br J Pharmacol, vol.147, pp.707-713, 2006. ,
Cysteinyl leukotrienes and their receptors; emerging concepts, Allergy Asthma Immunol Res, vol.6, pp.288-295, 2014. ,
Leukotriene receptor expression in mast cells is affected by their agonists, Cell Immunol, vol.317, pp.37-47, 2017. ,
Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells, Proc Natl Acad Sci USA, vol.98, pp.7964-7969, 2001. ,
Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R, Proc Natl Acad Sci, vol.100, pp.11589-11593, 2003. ,
Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling, J Immunol, vol.177, pp.2755-2759, 2006. ,
Leukotriene B4 receptors BLT1 and BLT2: Expression and function in human and murine mast cells, J Immunol, vol.177, pp.3439-3447, 2006. ,
CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells, Blood, vol.110, pp.3263-3270, 2007. ,
IgE receptor-mediated histamine release in human lung mast cells: Modulation by purinergic receptor ligands, Ann Clin Lab Sci, vol.46, pp.463-469, 2016. ,
Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3, J Allergy Clin Immunol, vol.137, pp.289-298, 2016. ,
Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors, J Exp Med, vol.201, pp.1961-1971, 2005. ,
Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis, Immunity, vol.28, pp.581-589, 2008. ,
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions, J Allergy Clin Immunol, vol.124, pp.301-302, 2009. ,
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis, N Engl J Med, vol.358, pp.28-35, 2008. ,
Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis, J Allergy Clin Immunol, vol.135, pp.1424-1432, 2015. ,
Activation of human mast cells through the platelet-activating factor receptor, J Allergy Clin Immunol, vol.125, pp.1137-1145, 2010. ,
Mast cell adenosine receptors function: A focus on the a3 adenosine receptor and inflammation, Front Immunol, vol.3, p.134, 2012. ,
Adenosine receptors and asthma, Br J Pharmacol, vol.153, issue.1, pp.446-456, 2008. ,
Adenosine-induced bronchoconstriction in asthma: Role of mast cell-mediator release, J Allergy Clin Immunol, vol.75, pp.272-278, 1985. ,
Why do asthmatic subjects respond so strongly to inhaled adenosine?, Life Sci, vol.69, pp.1225-1240, 2001. ,
Intracellular adenosine inhibits IgE-dependent degranulation of human skin mast cells, J Clin Immunol, vol.33, pp.1349-1359, 2013. ,
Enhanced mast cell activation in mice deficient in the A2b adenosine receptor, J Exp Med, vol.204, pp.117-128, 2007. ,
A(2B) adenosine receptors in immunity and inflammation, Trends Immunol, vol.30, pp.263-270, 2009. ,
Disparity in FcepsilonRI-induced degranulation of primary human lung and skin mast cells exposed to adenosine, J Clin Immunol, vol.31, pp.479-487, 2011. ,
Role of CCL7 in type I hypersensitivity reactions in murine experimental allergic conjunctivitis, J Immunol, vol.198, pp.645-656, 2017. ,
Mast cell chemotaxis -Chemoattractants and signaling pathways, Front Immunol, vol.3, p.119, 2012. ,
Vibratory urticaria associated with a missense variant in ADGRE2, N Engl J Med, vol.374, pp.656-663, 2016. ,
Nuclear receptors and their selective pharmacologic modulators, Pharmacol Rev, vol.65, pp.710-778, 2013. ,
Nuclear receptor minireview series, J Biol Chem, vol.276, pp.36863-36864, 2001. ,
Molecular mechanisms of glucocorticoid action in mast cells, Mol Cell Endocrinol, vol.380, pp.119-126, 2013. ,
Immunoprofiling of human uterine mast cells identifies three phenotypes and expression of ERbeta and glucocorticoid receptor, vol.6, p.667, 2017. ,
Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism, Allergy, vol.63, pp.1177-1185, 2008. ,
Localization and dynamics of glucocorticoid receptor at the plasma membrane of activated mast cells, Small, vol.10, pp.1991-1998, 2014. ,
The hypothalamicpituitary-gonadal axis: Immune function and autoimmunity, J Endocrinol, vol.176, pp.293-304, 2003. ,
Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation, PLoS ONE, vol.5, p.14409, 2010. ,
Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE-independent mast cell degranulation elicited by neuromuscular blocking agents, Exp Dermatol, vol.19, pp.302-304, 2010. ,
Progesterone inhibits mast cell secretion, Int J Immunopathol Pharmacol, vol.19, pp.787-794, 2006. ,
Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways, Thorax, vol.56, pp.205-211, 2001. ,
Role of female sex hormones, estradiol and progesterone, in mast cell behavior, Front Immunol, vol.3, p.169, 2012. ,
The impact of sex and sex hormones on lung physiology and disease: Lessons from animal studies, Am J Physiol Lung Cell Mol Physiol, vol.293, pp.272-278, 2007. ,
Influence of sex in immunoglobulin levels, Nature, vol.214, pp.1224-1225, 1967. ,
The effects of adrenocortical hormones, adrenocorticotrophic hormone and pregnancy on skin transplantation immunity in mice, J Endocrinol, vol.14, pp.240-256, 1956. ,
Estrogen effects in allergy and asthma, Curr Opin Allergy Clin Immunol, vol.13, pp.92-99, 2013. ,
The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organization, Ann Allergy Asthma Immunol, vol.91, pp.553-558, 2003. ,
Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment, BMC Pharmacol, vol.4, p.4, 2004. ,
Regulation of allergic lung inflammation in rats: Interaction between estradiol and corticosterone, NeuroImmunoModulation, vol.11, pp.20-27, 2004. ,
Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx, Mol Immunol, vol.44, pp.1977-1985, 2007. ,
Gender-related effects of sex steroids on histamine release and FcepsilonRI expression in rat peritoneal mast cells, J Immunol Res, p.351829, 2015. ,
Extranuclear steroid receptors: Roles in modulation of cell functions, Mol Endocrinol, vol.25, pp.377-384, 2011. ,
Safeguarding of fetal growth by mast cells and natural killer cells: Deficiency of one is counterbalanced by the other, Front Immunol, vol.8, p.711, 2017. ,
Mast cells, estrogens, and cryptorchidism: A histological based review, Transl Androl Urol, vol.1, pp.97-102, 2012. ,
Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation, Mol Immunol, vol.63, pp.69-73, 2015. ,
Aryl hydrocarbon receptor ligand effects in RBL2H3 cells, J Immunotoxicol, vol.9, pp.327-337, 2012. ,
The aryl hydrocarbon receptor modulates acute and late mast cell responses, J Immunol, vol.189, pp.120-127, 2012. ,
Aryl hydrocarbon receptor controls murine mast cell homeostasis, Blood, vol.121, pp.3195-3204, 2013. ,
A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor, Allergy, vol.69, pp.445-452, 2014. ,
Normal mast cell numbers in the tissues of AhR-deficient mice, Exp Dermatol, vol.25, pp.62-63, 2015. ,
Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis, J Immunol, vol.187, pp.490-500, 2011. ,
Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques, J Pathol, vol.220, pp.499-508, 2010. ,
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents, Trends Mol Med, vol.8, pp.174-179, 2002. ,
Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on mast cell proliferation and A23187-induced histamine release, also accompanied by a decreased c-kit receptor, Arch Dermatol Res, vol.288, pp.709-715, 1996. ,
Mechanisms of vitamin D(3) metabolite repression of IgE-dependent mast cell activation, J Allergy Clin Immunol, vol.133, pp.1356-1364, 2014. ,
1,25-Dihydroxyvitamin D3 enhances degranulation of mast cells, Mol Cell Endocrinol, vol.142, pp.49-55, 1998. ,
VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3, J Leukoc Biol, vol.81, pp.250-262, 2007. ,
Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice, J Exp Med, vol.207, pp.455-463, 2010. ,
Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators, Annu Rev Pharmacol Toxicol, vol.40, pp.491-518, 2000. ,
Peroxisome proliferatoractivated receptors are expressed in human cultured mast cells: A possible role of these receptors in negative regulation of mast cell activation, Eur J Immunol, vol.30, pp.3363-3370, 2000. ,
Peroxisome proliferatoractivated receptors are expressed in mouse bone marrow-derived mast cells, FEBS Lett, vol.467, pp.259-262, 2000. ,
Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells, J Biol Chem, vol.283, pp.16477-16487, 2008. ,
Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases, Allergy, vol.63, pp.1136-1147, 2008. ,
A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis, Arch Dermatol, vol.144, pp.84-88, 2008. ,
Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators, J Allergy Clin Immunol, vol.125, pp.161-165, 2010. ,
Peroxisome proliferator-activated receptor gamma agonist suppresses mast cell maturation and induces apoptosis, Mol Med Rep, vol.16, pp.1793-1800, 2015. ,
Peroxisome proliferatoractivated receptor-beta/delta modulates mast cell phenotype, Immunology, vol.150, pp.456-467, 2017. ,
PAMPs and alarmins: All we need to know about danger, J Leukoc Biol, vol.81, pp.1-5, 2007. ,
IL-1alpha, IL-33 and S100 proteins: Dual-function alarmins, Cell Mol Immunol, vol.14, pp.43-64, 2017. ,
IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells, J Immunol, vol.171, pp.4830-4836, 2003. ,
Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin, Br J Pharmacol, vol.148, pp.208-215, 2006. ,
In activated mast cells, IL-1 upregulates the production of several Th2-related cytokines including IL-9, J Immunol, vol.164, pp.5556-5563, 2000. ,
Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin, J Allergy Clin Immunol, vol.130, pp.225-232, 2012. ,
The role of IL-33 and mast cells in allergy and inflammation, Clin Transl Allergy, vol.5, p.33, 2015. ,
IL-33 can promote survival, adhesion and cytokine production in human mast cells, Lab Invest, vol.87, pp.971-978, 2007. ,
IL-33/ST2 axis promotes mast cell survival via BCLXL, Proc Natl Acad Sci USA, vol.111, pp.10281-10286, 2014. ,
IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals, J Leukoc Biol, vol.82, pp.1481-1490, 2007. ,
Murine mast cells secrete and respond to interleukin-33, J Interferon Cytokine Res, vol.34, pp.141-147, 2014. ,
The role of interleukin-33 in chronic allergic conjunctivitis, Invest Ophthalmol Vis Sci, vol.50, pp.4646-4652, 2009. ,
Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways, J Biol Regul Homeost Agents, vol.28, pp.575-585, 2014. ,
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells, Cytokine, vol.40, pp.216-225, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01715320
Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice, Allergy, vol.67, pp.1118-1126, 2012. ,
Interleukin-33 and mast cells bridge innate and adaptive immunity: From the allergologist's perspective, Int Neurourol J, vol.19, pp.142-150, 2015. ,
IL-33 is produced by mast cells and regulates IgE-dependent inflammation, PLoS ONE, vol.5, p.11944, 2010. ,
IL-33 exacerbates antigeninduced arthritis by activating mast cells, Proc Natl Acad Sci, vol.105, pp.10913-10918, 2008. ,
MK2/3 are pivotal for IL-33-induced and mast cell-dependent leukocyte recruitment and the resulting skin inflammation, J Immunol, vol.197, pp.3662-3668, 2016. ,
SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors, Proc Natl Acad Sci, vol.114, pp.4002-4009, 2017. ,
Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33, Eur J Immunol, vol.41, pp.760-772, 2011. ,
IL-33 promotes ICAM-1 expression via NF-kB in murine mast cells, Allergol Int, vol.65, pp.158-165, 2016. ,
IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells, J Allergy Clin Immunol, vol.138, pp.1356-1366, 2016. ,
Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells, Allergy, vol.70, pp.514-521, 2015. ,
IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell level, J Allergy Clin Immunol, vol.140, pp.497-509, 2017. ,
IL-33 induces a hyporesponsive phenotype in human and mouse mast cells, J Immunol, vol.190, pp.531-538, 2013. ,
Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells, Proc Natl Acad Sci, vol.111, pp.15502-15507, 2014. ,
Highly selective cleavage of cytokines and chemokines by the human mast cell chymase and neutrophil cathepsin G, J Immunol, vol.198, pp.1474-1483, 2017. ,
Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation, J Biol Chem, vol.289, pp.237-250, 2014. ,
Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation, Mucosal Immunol, vol.6, pp.911-920, 2013. ,
IL-33 drives airway hyperresponsiveness through IL-13-mediated mast cell: Airway smooth muscle crosstalk, Allergy, vol.70, pp.556-567, 2015. ,
An interleukin-33-mast cellinterleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers, Immunity, vol.43, pp.175-186, 2015. ,
IL-33 and IgE stimulate mast cell production of IL-2 and regulatory T cell expansion in allergic dermatitis, Clin Exp Allergy, vol.47, pp.1409-1416, 2017. ,
Ability of interleukin-33-and immune complex-triggered activation of human mast cells to down-regulate monocyte-mediated immune responses, Arthritis Rheumatol, vol.67, pp.2343-2353, 2015. ,
HMGB1 develops enhanced proinflammatory activity by binding to cytokines, J Immunol, vol.180, pp.2531-2537, 2008. ,
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4, J Exp Med, vol.209, pp.551-563, 2012. ,
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE, J Exp Med, vol.205, pp.3007-3018, 2008. ,
Advanced glycation end products (AGEs) activate mast cells, Br J Pharmacol, vol.161, pp.442-455, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00515551
Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa, J Immunol, vol.192, pp.4032-4042, 2014. ,
Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation, J Allergy Clin Immunol, vol.134, pp.440-450, 2014. ,
Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33, J Exp Med, vol.209, pp.1505-1517, 2012. ,
P2 receptor-mediated signaling in mast cell biology, Purinergic Signal, vol.6, pp.3-17, 2010. ,
ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor, J Immunol, vol.189, pp.4112-4122, 2012. ,
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors, Nat Commun, vol.3, p.1034, 2012. ,
P2X7 receptors induce degranulation in human mast cells, Purinergic Signal, vol.12, pp.235-246, 2016. ,
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells, Nat Med, vol.13, pp.913-919, 2007. ,
Integrins: Versatility, modulation, and signaling in cell adhesion, Cell, vol.69, pp.11-25, 1992. ,
Differential expression of cell surface integrins on human mast cells and human basophils, Ann Hematol, vol.65, pp.10-16, 1992. ,
Developmental origin and functional specialization of mast cell subsets, Immunity, vol.37, pp.25-33, 2012. ,
Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing, J Exp Med, vol.194, pp.1243-1252, 2001. ,
Tie2 signaling enhances mast cell progenitor adhesion to vascular cell adhesion molecule-1 (VCAM-1) through alpha4beta1 integrin, PLoS ONE, vol.10, p.144436, 2015. ,
VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment, J Virol, vol.76, pp.1109-1123, 2002. ,
Novel collectin/C1q receptor mediates mast cell activation and innate immunity, Blood, vol.107, pp.143-150, 2006. ,
Collagen distribution and expression of collagen-binding alpha1beta1 (VLA-1) and alpha2beta1 (VLA-2) integrins on CD4 and CD8 T cells during influenza infection, J Immunol, vol.178, pp.4506-4516, 2007. ,
Engagement of collagenbinding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells, Cancer Res, vol.67, pp.2030-2039, 2007. ,
Integrins and cadherins join forces to form adhesive networks, J Cell Sci, vol.124, pp.1183-1193, 2011. ,
Regulation of inflammation by collagen-binding integrins alpha-1beta1 and alpha2beta1 in models of hypersensitivity and arthritis, J Clin Invest, vol.105, pp.721-729, 2000. ,
Mast cell-mediated inflammatory responses require the alpha 2 beta 1 integrin, Blood, vol.103, pp.2214-2220, 2004. ,
beta7 Integrin controls mast cell recruitment, whereas alphaE integrin modulates the number and function of CD8 + T cells in immune complex-mediated tissue injury, J Immunol, vol.192, pp.4112-4121, 2014. ,
Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation, J Biol Chem, vol.284, pp.31463-31472, 2009. ,
Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen, J Immunol, vol.176, pp.52-60, 2006. ,
Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways, J Biomech, vol.46, pp.788-795, 2013. ,
Tetraspanins and transmembrane adaptor proteins as plasma membrane organizers-mast cell case, Front Cell Dev Biol, vol.4, p.43, 2016. ,
The tetraspanin web modulates immune-signalling complexes, Nat Rev Immunol, vol.5, pp.136-148, 2005. ,
Tetraspanins function as regulators of cellular signaling, Front Cell Dev Biol, vol.5, p.34, 2017. ,
Protein-protein interactions in the tetraspanin web, Physiology (Bethesda), vol.20, pp.218-224, 2005. ,
Targeting of tetraspanin proteins-potential benefits and strategies, Nat Rev Drug Discov, vol.7, pp.747-758, 2008. ,
P-24: A human leukemiaassociated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody, J Exp Med, vol.153, pp.726-731, 1981. ,
Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor, Blood, vol.107, pp.135-142, 2006. ,
Cross-talk between tetraspanin CD9 and transmembrane adaptor protein non-T cell activation linker (NTAL) in mast cell activation and chemotaxis, J Biol Chem, vol.288, pp.9801-9814, 2013. ,
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes, Immunology, vol.87, pp.535-543, 1996. ,
Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals, Cancer Cell, vol.21, pp.694-708, 2012. ,
Tetraspanin CD37 regulates beta2 integrin-mediated adhesion and migration in neutrophils, J Immunol, vol.195, pp.5770-5779, 2015. ,
CD53, a suppressor of inflammatory cytokine production, is associated with population asthma risk via the functional promoter polymorphism -1560 C>T, Biochim Biophys Acta, vol.1830, pp.3011-3018, 2013. ,
Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients, J Leukoc Biol, vol.81, pp.934-941, 2007. ,
CD63/Pltgp40: A platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491, Blood, vol.78, pp.280-284, 1991. ,
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors, Hybridoma, vol.4, pp.243-255, 1985. ,
Monitoring human basophil activation via CD63 monoclonal antibody 435, J Allergy Clin Immunol, vol.88, pp.328-338, 1991. ,
Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complex, J Cell Biol, vol.215, pp.203-216, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01415529
A granular variant of CD63 is a regulator of repeated human mast cell degranulation, Allergy, vol.65, pp.1242-1255, 2010. ,
Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function, Mol Cell Biol, vol.29, pp.1083-1094, 2009. ,
Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo, J Exp Med, vol.201, pp.385-396, 2005. ,
Negative regulation of Fc epsilon RI-mediated degranulation by CD81, J Exp Med, vol.186, pp.1307-1314, 1997. ,
Tetraspanin CD151 is a negative regulator of FcepsilonRI-mediated mast cell activation, J Immunol, vol.195, pp.1377-1387, 2015. ,
Mast cell-orchestrated immunity to pathogens, Nat Rev Immunol, vol.10, pp.440-452, 2010. ,
Mast cells as cellular sensors in inflammation and immunity, Front Immunol, vol.2, p.37, 2011. ,
Immunomodulatory mast cells: Negative, as well as positive, regulators of immunity, Nat Rev Immunol, vol.8, pp.478-486, 2008. ,
Mast cells in renal inflammation and fibrosis: Lessons learnt from animal studies, Mol Immunol, vol.63, pp.86-93, 2015. ,
Rheostatic functions of mast cells in the control of innate and adaptive immune responses, Trends Immunol, vol.38, pp.648-656, 2017. ,
Expression profiling of constitutive mast cells reveals a unique identity within the immune system, Nat Immunol, vol.17, pp.878-887, 2016. ,
Redefinition of the human mast cell transcriptome by deep-CAGE sequencing, Blood, vol.123, pp.58-67, 2014. ,
Non-IgE mediated mast cell activation, Immunol Rev, vol.282, pp.87-113, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02323281